raav1.tmck.human-alpha-sarcoglycan
Gene therapyexperimental
Clinical trial activity
1 trials · 3 clinical orgs · 0 marketing orgs
Phase 1
1
Phase 2
0
Phase 3
0
Phase 4
0
Earliest trial started Mar 1, 2008 (NCT00494195)
Timeline
2000s
- Jan 1, 2008
Earliest Phase 1 Sponsor(trial)
Indications
Studied for
Mechanism of action
- Gamma-sarcoglycanSupplementation
supplementation - SGCG
Chemistry & pharmacology
Oral
No
Parenteral
No
Topical
No
Also known as
- raav1.tmck.human-alpha-sarcoglycan
Clinical trials
| NCT ID | Phase | Start date | Sponsor(s) |
|---|---|---|---|
| NCT00494195 | Phase 1 | Mar 1, 2008 | Muscular Dystrophy Association, National Institute of Arthritis and Musculoskeletal and Skin Diseases (NIAMS), Ohio State University |
Showing 1 of 1 trials
Page 1 / 1
Organizations
Research & Development (3)
| Organization | Org type | Trials | As lead sponsor | Phases | Earliest year |
|---|---|---|---|---|---|
| Muscular Dystrophy Association | Academic/Hospital | 1 | 0 | 1 | 2008 |
| National Institute of Arthritis and Musculoskeletal and Skin Diseases (NIAMS) | Government | 1 | 0 | 1 | 2008 |
| Ohio State University | Academic/Hospital | 1 | 1 | 1 | 2008 |
3 organizations
Page 1 / 1